Trial · NCT01041638
Adverse events357
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 357
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | 13200-Anemia | Blood and lymphatic system disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 99 | 104 | 1,181 |
| other | 17200-Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 2 | 104 | 2 |
| other | 18100-Bone marrow hypocellular | Blood and lymphatic system disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 25800-Disseminated intravascular coagulation | Blood and lymphatic system disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 20100-Cardiac disorders - Other | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 6 | 104 | 16 |
| other | 21300-Chest pain - cardiac | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 3 | 104 | 3 |
| other | 61000-Palpitations | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 2 | 104 | 2 |
| other | 63100-Pericardial effusion | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 2 | 104 | 3 |
| other | 74200-Sinus bradycardia | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 7 | 104 | 18 |
| other | 74500-Sinus tachycardia | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 85 | 104 | 740 |
| other | 78900-Supraventricular tachycardia | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 3 | 104 | 5 |
| other | 81400-Tricuspid valve disease | Cardiac disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 27900-Ear and labyrinth disorders - Other | Ear and labyrinth disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 2 | 104 | 2 |
| other | 28000-Ear pain | Ear and labyrinth disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 3 | 104 | 3 |
| other | 31600-External ear pain | Ear and labyrinth disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 38900-Hearing impaired | Ear and labyrinth disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 10 | 104 | 10 |
| other | 11200-Adrenal insufficiency | Endocrine disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 29200-Endocrine disorders - Other | Endocrine disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 41900-Hyperparathyroidism | Endocrine disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 1 | 104 | 1 |
| other | 42200-Hyperthyroidism | Endocrine disorders | Chimeric Antibody 14.18 With GM-CSF, IL-2 and Isotretinoin | 5 | 104 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01041638/events